Saturday, May 04, 2024

Training | 2016.07.19

Braeburn Pharmaceuticals to Conduct First Series of Probuphine® (buprenorphine) Implant Trainings in Houston on July 22, 23 and 24 for Qualified Healthcare Providers

Master Trainer Dr. Matt Torrington of the UCLA Integrated Substance Abuse Programs works closely with qualified healthcare providers to teach them best practices for insertion and removal of the Probuphine implant, a new treatment option for opioid dependence. HOUSTON, July 19, 2016 /PRNewswire/ -- Braeburn Pharmaceuticals announces that healthcare provider training and certification for Probuphine will take place on July 22, 23 and 24 in Houston. Approved by the Food and Drug Administration (FDA) on May 26, 2016, Probuphine is the first...


 

For more information, please visit
http://www.prnewswire.com/news-releases/[...]hcare-providers-300300847.html

You need to login to post comments.

Feed last updated 2024/05/31 @9:05 PM

0 COMMENTS:

Follow us on Follow Us on Facebook Follow Us on Twitter
©2006 Translations News